1681.HK
1681.HK
KYG2524A1031
CONSUN PHARMA
Loading chart...

Company Profile

-

Related stocks

603707.SS
603707.SS • China
NANJING KING-FRIEND BIOCHEMICAL
8.18 CNY
1.98B USD 1Y -21.6%
002099.SZ
002099.SZ • China
HISOAR
6.32 CNY
1.53B USD 1Y +8%
600216.SS
600216.SS • China
ZHEJIANG MEDICINE
12.59 CNY
1.81B USD 1Y -12.9%
300401.SZ
300401.SZ • China
GARDEN BIO-CHEM
14.65 CNY
1.19B USD 1Y +2.5%
300363.SZ
300363.SZ • China
PORTON
23.68 CNY
1.93B USD 1Y -9.3%
688321.SS
688321.SS • China
SHENZHEN CHIPSCREEN BIOSCIENCES
24.31 CNY
1.61B USD 1Y -23.6%
300725.SZ
300725.SZ • China
PHARMABLOCK
51.01 CNY
1.78B USD 1Y +22.3%
600572.SS
600572.SS • China
ZHEJIANG CONBA PHARMACEUTICAL C
4.41 CNY
1.68B USD 1Y +0.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
China
Region
Asia-Pacific
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
38.4% p.a.
Max Drawdown (5Y)
-38.6%
Sharpe Ratio (5Y)
0.79
Beta Factor
0.43
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (38.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -69.9% in the extended horizon.
ende